Profil
Thomas Paul Castellano is currently Director at Novo Nordisk Belgium Manufacturing Holding SA since 2021, Director at Catalent France Beinheim SA, and Chief Financial Officer & Director at Abzena Ltd. since 2023.
Formerly, Mr. Castellano was Chief Financial Officer & Senior Vice President at Catalent, Inc. from 2022 to 2023.
Education includes undergraduate and MBA degrees from Seton Hall University.
Aktiva positioner av Thomas Castellano
| Företag | Position | Start |
|---|---|---|
| ABZENA PLC | Finansdirektör/CFO | 2023-06-05 |
Catalent France Beinheim SA
Catalent France Beinheim SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Direktör/Styrelseledamot | - |
Catalent Belgium Holding SA | Direktör/Styrelseledamot | 2021-08-05 |
Tidigare kända positioner av Thomas Castellano
| Företag | Position | Slut |
|---|---|---|
| CATALENT, INC. | Finansdirektör/CFO | 2023-04-13 |
Thomas Castellanos utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Seton Hall University
Seton Hall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Catalent Belgium Holding SA | |
Catalent France Beinheim SA
Catalent France Beinheim SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Catalent, Inc.
Catalent, Inc. Pharmaceuticals: MajorHealth Technology Provides delivery technologies and development solutions | Health Technology |
Abzena Ltd.
Abzena Ltd. BiotechnologyHealth Technology Engages in discovery, development and manufactures biologics drugs | Health Technology |
















